Organs à la carte?
Turning the science fiction of synthetic organs into medical fact - that's the vision of CELLBRICKS. The startup is showcasing its innovative 3D bioprinting technology at the TU Berlin pavilion during LABVOLUTION 2019.3 Apr 2019 Trendspots Editorial Office
With some 33,500 students, around 100 different courses and 40 institutes, the Technische Universität Berlin is one of Germany’s biggest, most prestigious and tradition-steeped universities. Its teaching and research efforts, high-caliber graduates and cutting-edge, service-oriented management have earned it an outstanding global reputation, right at the heart of Europe. The seven faculties cover a broad range of disciplines that provide a unique combination of natural sciences and technology with planning, business and social sciences, not to mention humanities. At this year's LABVOLUTION, the TU Berlin is once again hosting a pavilion to showcase a series of projects proposing exciting, future-focused solutions - including bioprinting technology pioneered by the startup CELLBRICKS.
CELLBRICKS believes 3D bioprinting technology holds the key to solving a range of 21st-century medical challenges. For instance, 3D-printed cell structures simulating human tissue and organs could well overhaul established approaches to developing medicines. Not only might this put an end to testing on animals, but the customized, precision medicine it enables could revolutionize medical treatments. To pave the way for this major advance, CELLBRICKS is developing complex biological cell culture systems on a proprietary stereolithography-based bioprinting platform. The team predicts this will set entirely new standards in the quality, speed and accessibility of three-dimensional cell culture systems.
Interested in news about exhibitors, top offers and trends in the industry?
Your web browser is outdated. Update your browser for more security, speed and optimal presentation of this page.Update Browser